Aimosti The European alternative to Genomelink

Submitted

Genome re-analysis from Finland based on existing DNA data

Aimosti Logo
Finland Gesundheit Software instead of Genomelink

About Aimosti

Aimosti is a service for re-analyzing existing DNA data that users upload themselves. Variants are matched against current clinical and research databases and presented with versioning. The provider emphasizes that this is not a medical test or diagnosis.

Highlights

  • Analyzes existing genome or genotyping raw data, no test kit
  • Modules for clinical findings, carrier status and pharmacogenomics
  • Automatic re-analysis when the evidence changes
  • Results with source attribution and versioning
  • Raw data is deleted by default after the analysis

Why European?

  • Genetic data as a special category stays in Finland and the EU
  • Explicit and revocable consent under GDPR Article 9
  • Data is not sold or shared according to the provider
  • EU jurisdiction for highly sensitive health data

Pricing

Chip report from EUR 49 · whole-genome report EUR 89 (one-time) · update subscription EUR 29/year.

Frequently asked questions about Aimosti

What is Aimosti and what is it used for? +

Aimosti is a service from Aimosti Oy in Finland that re-analyzes existing DNA data. Users upload raw data they already own, for example from whole-genome sequencing or genotyping chips. Aimosti matches the variants against databases such as ClinVar, CPIC and the GWAS Catalog and shows what the current evidence says about a variant. No test kit is sold; the service works exclusively with data that already exists.

Does Aimosti run on European infrastructure? +

According to the provider, data is processed and stored in Finland and does not leave the EU, with encrypted transfer. A specific cloud provider is not named on the public pages. Aimosti processes genetic data as a special category under GDPR Article 9 and obtains explicit, revocable consent for this. Raw data is deleted by default after the analysis, and deletion on request is possible.

Is Aimosti a medical test? +

Aimosti explicitly states that it is not a medical test or diagnosis. The service restates the existing scientific evidence on variants and points users to confirm findings with medical professionals and a validated test. It does not replace medical advice or a clinical examination. The results are for information and are presented with sources and version status.

Try Aimosti

Genome re-analysis from Finland based on existing DNA data

Visit Aimosti Website →
Listed on only-eu.eu badge Link to this product. Support our mission.

HTML snippet for your website:

<a href="https://only-eu.eu/en/categories/health-software/aimosti?ref=badge" target="_blank" rel="noopener noreferrer">
  <img src="https://only-eu.eu/badge/listed-on-only-eu.svg" alt="Listed on only-eu.eu" width="220" height="56" />
</a>
More info →

Entry verified on 05.08.2026